Oss
Noord-Brabant
Acerta Pharma
discovers and develops drugs for oncology and autoimmune diseases... Read moreAcerta Pharma
discovers and develops drugs for oncology and autoimmune diseases... Read moreNews
Apr 14, 2021
MarketScreener
Acerta Pharma: Veracyte : Announces Key Milestone in Companion Diagnostics Program With Acerta Pharma Using LymphMark Lymphoma Subtyping Test
Jun 23, 2020
Pharmabiz
Acerta Pharma: Ascentage Pharma inks collaboration with Acerta Pharma to evaluate combination of Bcl2 and BTK inhibitors to treat r/r CLL & SLL
Jan 15, 2020
Seeking Alpha
Acerta Pharma: Veracyte: Adding Another Big Pharma Partner Backs Bullish Outlook
Jan 08, 2020
BioSpace
Acerta Pharma: Veracyte Announces Biopharmaceutical Collaboration with Acerta Pharma
May 14, 2019
Pharmabiz
Acerta Pharma: Forty Seven, Acerta Pharma collaborate to evaluate novel immuno─oncology triple combination in DLBCL
May 10, 2019
BioSpace
Acerta Pharma: Forty Seven Inc. and Acerta Enter Collaboration to Evaluate Novel Immuno-Oncology Triple Combination in Diffuse Large B-cell Lymphoma
Dec 04, 2018
The Pharma Letter
Acerta Pharma: AstraZeneca presents more positive data for Calquence at ASH 2018
Dec 13, 2017
Business Wire India
Press Release: Acerta Pharma : AstraZeneca's Calquence (acalabrutinib) Shows Potential in Chronic Lymphocytic Leukaemia Trials
Dec 11, 2017
PharmiWeb
Acerta Pharma: AstraZeneca's Calquence (acalabrutinib) Shows Potential in Chronic Lymphocytic Leukaemia Trials
Nov 01, 2017
M2 PressWIRE
Press Release: Acerta Pharma : AstraZeneca passes US FDA accelerated approval for CALQUENCE to treat mantle cell lymphoma (MCL)
Acerta Pharma Competitors
1
2
3
4
5
6
7
8
9
10